Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMatthew Holderfield, Elena S. Koltun, Mallika Singh et al.|Nature|2024Cited by 319
Using Matched Molecular Series as a Predictive Tool To Optimize Biological ActivityNoel M. O’Boyle, Adrian L. Gill, Jonas Boström et al.|Journal of Medicinal Chemistry|2014Cited by 62
A neomorphic protein interface catalyzes covalent inhibition of RAS <sup>G12D</sup> aspartic acid in tumorsCaroline E. Weller, David Wildes, G. Leslie Burnett et al.|Science|2025Cited by 31
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMallika Singh, David Wildes, Matthew Holderfield et al.|Research Square|2023Cited by 5